Palomino Laboratories (PALX) Cash from Operations (2023 - 2025)

Palomino Laboratories (PALX) reported Cash from Operations of 343500.0 for Q3 2025, down 1189.47% on a YoY basis from 31529.0 in Q3 2024, and down 582.29% sequentially from 50345.0 in Q2 2025.

Palomino Laboratories (PALX) Cash from Operations (2023 - 2025) Analysis & Trends

Palomino Laboratories (PALX) has 3 years of Cash from Operations data on file, last reported at 343500.0 in Q3 2025.

  • For the quarter ending Q3 2025, Cash from Operations fell 1189.47% year-over-year to 343500.0; the trailing twelve-month figure through Sep 2025 stood at 558260.0 (changed N/A YoY), and the FY2024 full-year result was 166637.0, down 109.93% from the prior year.
  • Cash from Operations declined to 343500.0 in Q3 2025, from 50345.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 31529.0 in Q3 2024 to a low of 343500.0 in Q3 2025.
  • A 3-year average of 97249.5 and a median of 53555.5 in 2023 frame the typical range for Cash from Operations.
  • Across the five-year window, Cash from Operations slumped 195.01% in 2024 and plunged 1189.47% in 2025, its largest moves.
  • Tracing PALX's Cash from Operations over 3 years: stood at 56766.0 in 2023, then tumbled by 195.01% to 167467.0 in 2024, then tumbled by 105.12% to 343500.0 in 2025.
  • Business Quant data shows PALX's Cash from Operations at 343500.0 in Q3 2025, 50345.0 in Q2 2025, and 3052.0 in Q1 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Sep 30, 2025 -343,500.00
Sep 30, 2025 -343,500.00
Jun 30, 2025 -50,345.00
Jun 30, 2025 -50,345.00
Mar 31, 2025 3,052.00
Mar 31, 2025 3,052.00
Dec 31, 2024 -167,467.00
Dec 31, 2024 -167,467.00
Sep 30, 2024 31,529.00
Sep 30, 2024 31,529.00
Dec 31, 2023 -56,766.00
Dec 31, 2023 -56,766.00